Literature DB >> 25393421

Computed tomographic measurement of airway remodeling and emphysema in advanced chronic obstructive pulmonary disease. Correlation with pulmonary hypertension.

Gaël Dournes1, François Laurent, Florence Coste, Claire Dromer, Elodie Blanchard, François Picard, Fabien Baldacci, Michel Montaudon, Pierre-Olivier Girodet, Roger Marthan, Patrick Berger.   

Abstract

RATIONALE: Pulmonary hypertension (PH) is an established complication of advanced chronic obstructive pulmonary disease (COPD) associated with increased mortality. The mechanisms coupling PH and bronchial obstruction are unknown; in particular, PH appears to be unrelated to emphysema. We hypothesized that computed tomographic (CT) measurement of airway remodeling instead of emphysema may correlate with PH in COPD.
OBJECTIVES: We aimed to describe the clinical and CT characteristics of patients with COPD with or without PH and to correlate CT measurements of airway remodeling and emphysema with PH.
METHODS: Data were retrieved from 60 COPD patients who underwent both right heart catheterization and computed tomography in a period of stability and had no other disease known to cause PH. CT measurement of airway wall thickness (WT-Pi10) was used to assess airway remodeling and low lung area percentage (LAA%) to quantify emphysema extent.
MEASUREMENTS AND MAIN RESULTS: Thirty-four of the sixty patients with COPD had PH (mean pulmonary arterial pressure [PAPm] ≥ 25 mm Hg). There was no difference between the two groups regarding age, sex, and spirometric results, whereas there was more profound hypoxemia in the PH group. WT-Pi10 was increased in the patients with COPD and PH and correlated with PAPm (ρ = 0.62; P < 0.001). Conversely, there was no difference or correlation between PAPm and LAA% (ρ = 0.12; P = 0.33). In multivariate analysis (R(2) = 0.53), WT-Pi10 was the independent predictor most associated with PAPm elevation, as compared to hypoxia (PaO2) or pulmonary arterial enlargement (diameter ratio between the pulmonary arterial truncus and the ascending aorta).
CONCLUSIONS: This study demonstrates, for the first time to our knowledge, an association between structural alterations of bronchi and PH in COPD. Unlike quantification of emphysema, CT measurement of airway remodeling correlates with PAPm and could be used to estimate the severity of PH in COPD. Airway remodeling burden is not limited to airflow limitation in the assessment of COPD severity and mortality.

Entities:  

Keywords:  COPD; CT; pulmonary hypertension; remodeling

Mesh:

Year:  2015        PMID: 25393421     DOI: 10.1164/rccm.201408-1423OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  23 in total

1.  In Rotterdam, size really does matter: implications of pulmonary artery enlargement on mortality.

Authors:  Aline N Zouk; J Michael Wells
Journal:  Eur Respir J       Date:  2017-06-15       Impact factor: 16.671

2.  Comparison of low- and ultralow-dose computed tomography protocols for quantitative lung and airway assessment.

Authors:  Emily Hammond; Chelsea Sloan; John D Newell; Jered P Sieren; Melissa Saylor; Craig Vidal; Shayna Hogue; Frank De Stefano; Alexa Sieren; Eric A Hoffman; Jessica C Sieren
Journal:  Med Phys       Date:  2017-08-02       Impact factor: 4.071

Review 3.  Phenotype of Chronic Obstructive Pulmonary Disease Based on Computed Tomography-Defined Underlying Pathology.

Authors:  Won-Dong Kim
Journal:  Tuberc Respir Dis (Seoul)       Date:  2022-07-13

4.  Potential Role of CT Metrics in Chronic Obstructive Pulmonary Disease with Pulmonary Hypertension.

Authors:  Katsutoshi Ando; Hiroshi Kuraishi; Tetsutaro Nagaoka; Takeo Tsutsumi; Yoshito Hoshika; Toru Kimura; Hiroki Ienaga; Yoshiteru Morio; Kazuhisa Takahashi
Journal:  Lung       Date:  2015-10-09       Impact factor: 2.584

5.  Clinical, physiologic, and radiographic factors contributing to development of hypoxemia in moderate to severe COPD: a cohort study.

Authors:  J Michael Wells; Raul San Jose Estepar; Merry-Lynn N McDonald; Surya P Bhatt; Alejandro A Diaz; William C Bailey; Francine L Jacobson; Mark T Dransfield; George R Washko; Barry J Make; Richard Casaburi; Edwin J R van Beek; Eric A Hoffman; Frank C Sciurba; James D Crapo; Edwin K Silverman; Craig P Hersh
Journal:  BMC Pulm Med       Date:  2016-12-01       Impact factor: 3.317

6.  Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD.

Authors:  Yutaro Oki; Masahiro Kaneko; Yukari Fujimoto; Hideki Sakai; Shogo Misu; Yuji Mitani; Takumi Yamaguchi; Hisafumi Yasuda; Akira Ishikawa
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-11-22

7.  Alterations in plasma hyaluronic acid in patients with clinically stable COPD versus (non)smoking controls.

Authors:  Kiki Waeijen-Smit; Niki L Reynaert; Rosanne J H C G Beijers; Sarah Houben-Wilke; Sami O Simons; Martijn A Spruit; Frits M E Franssen
Journal:  Sci Rep       Date:  2021-08-05       Impact factor: 4.379

8.  Longitudinal Imaging-Based Clusters in Former Smokers of the COPD Cohort Associate with Clinical Characteristics: The SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS).

Authors:  Chunrui Zou; Frank Li; Jiwoong Choi; Babak Haghighi; Sanghun Choi; Prathish K Rajaraman; Alejandro P Comellas; John D Newell; Chang Hyun Lee; R Graham Barr; Eugene Bleecker; Christopher B Cooper; David Couper; Meilan Han; Nadia N Hansel; Richard E Kanner; Ella A Kazerooni; Eric C Kleerup; Fernando J Martinez; Wanda O'Neal; Robert Paine; Stephen I Rennard; Benjamin M Smith; Prescott G Woodruff; Eirc A Hoffman; Ching-Long Lin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-05-31

9.  Remodeling in asthma and COPD-recent concepts.

Authors:  Surinder Kumar Jindal
Journal:  Lung India       Date:  2016 Jan-Feb

10.  Accuracy of CT Pulmonary Artery Diameter for Pulmonary Hypertension in End-Stage COPD.

Authors:  Firdaus A Mohamed Hoesein; Tim Besselink; Esther Pompe; Erik-Jan Oudijk; Ed A de Graaf; J M Kwakkel-van Erp; Pim A de Jong; Bart Luijk
Journal:  Lung       Date:  2016-07-16       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.